Resultados de procura - Chang, Ching-Fu

PD-L1 Immunohistochemistry Comparability and Their Correlation with Clinical Characteristics in NSCLC por Wu, Chiao-En, Chang, Ching-Fu, Kou-Sheng, Liao, Chiang, Ju, Lee, Shih-Wei, Chiu, Yu-Chi

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study por Wu, Chiao-En, Chang, Ching-Fu, Huang, Chen-Yang, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Hsu, Ping-Chih, Chang, John Wen-Cheng

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma por Wu, Chiao-En, Chang, Ching-Fu, Huang, Chen-Yang, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Hsu, Ping-Chih, Chang, John Wen-Cheng

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model por Chang, Ching-Fu, Huang, Pei-Wei, Chen, Jen-Shi, Chen, Yen-Yang, Lu, Chang-Hsien, Chang, Pei-Hung, Hung, Yu-Shin, Chou, Wen-Chi

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI por Chang, John Wen-Cheng, Huang, Chen-Yang, Fang, Yueh-Fu, Chang, Ching-Fu, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Hsu, Ping-Chih, Wu, Chiao-En

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients por Chang, John Wen‐Cheng, Huang, Chen‐Yang, Fang, Yueh‐Fu, Chang, Ching‐Fu, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott, Hsu, Ping‐Chih, Wu, Chiao‐En

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy por Lin, Chia-Hsin, Hung, Tsung-Min, Chang, Yu-Chuan, Hsieh, Chia-Hsun, Shih, Ming-Chieh, Huang, Shih-Ming, Yang, Chan-Keng, Chang, Ching-Fu, Chan, Sheng-Chieh, Yap, Wing-Keen

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy por Huang, Pei‐Wei, Chang, Ching‐Fu, Hung, Chia‐Yen, Hsueh, Shun‐Wen, Chang, Pei‐Hung, Yeh, Kun‐Yun, Chen, Jen‐Shi, Chen, Yen‐Yang, Lu, Chang‐Hsien, Hung, Yu‐Shin, Chou, Wen‐Chi

Ligazón do recurso Ligazón do recurso Ligazón do recurso

The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies por Wu, Chiao-En, Yang, Chan-Keng, Peng, Meng-Ting, Huang, Pei-Wei, Chang, Ching-Fu, Yeh, Kun-Yun, Chen, Chun-Bing, Wang, Chih-Liang, Hsu, Chao-Wei, Chen, I-Wen, Lin, Cheng-Tao, Ueng, Shir-Hwa, Lin, Gigin, Lin, Yu-Fen, Cheng, Chi-Yuan, Chang, John Wen-Cheng

Ligazón do recurso Ligazón do recurso Ligazón do recurso